Can Credence Advertising Effects Be Isolated? Can They Be Negative?: Evidence from Pharmaceuticals

W. David Bradford and Andrew N. Kleit

Southern Economic Journal, 2011, vol. 78, issue 1, 167-190

Abstract: We explore the relative impact of informative versus the credence effects of direct‐to‐consumer advertising in the market for prescription drugs. In particular, we examine how advertising for statin medications affects the delay between diagnosis and pharmacological treatment for patients with elevated cholesterol, as well as the time between treatment initiation and therapy switching. Duration models of delay to treatment indicate that over some ranges, advertising increases the likelihood of treatment, while over other ranges greater advertising is associated with lower likelihood of treatment. Results for the switching behavior models indicate that on net, advertising tends to both discourage switching between drugs and encourage therapy continuation. However, the component of the advertising that represents credence effects is generally positive, which indicates that as patients' spell of drug usage lengthens, the Food and Drug Administration–required warnings in advertisements induce consumers to switch away from the pharmaceuticals they are using.

Date: 2011
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://doi.org/10.4284/0038-4038-78.1.167

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wly:soecon:v:78:y:2011:i:1:p:167-190

Access Statistics for this article

More articles in Southern Economic Journal from John Wiley & Sons
Bibliographic data for series maintained by Wiley Content Delivery ().